BioNet-Asia, DBV, University of Geneva deal

BioNet, DBV and the university partnered to develop a booster vaccine against pertussis through Phase I proof of concept. The vaccine will combine BioNet's recombinant non-toxic Pertussis Toxin (rPT) ...